Abstract
The reduction of NBT to formazan has been suggested as an indicator of the reduction potential of biological systems. An increase in the amount of reduced formazan reflects the activation of the hexose monophosphate shunt of phagocytes cultivated in vitro, as a result of cellular stimulation by chemical or biological factors, or during phagocytosis. This phenomenon has been widely used for the determination of activated phagocytes by different methods. However, the technical limitations of these methods have not been evaluated carefully. In the investigations presented here threesolvents for formazan, pyridine, dioxane and dimethylformamide, have been tested for their suitability as extraction agents. For each solvent the optimal wavelength for photometric evaluation has been determined and dose relation curves between dissolved formazan and OD have been established. Several factors (time, temperature, pH, contamination with water or acid) affecting the dissolving properties and stability of formazan in different solvents have been investigated. With the solvents tested, dioxane proved to be the most suitable agent for extracting NBF. Thus, a methodology for the quantitative evaluation of NBT has been established. This method can be used for the identification of activators as well as of inhibitors of the phagocyte system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
W. Weston, R.D. Dustin andS.K. Hecht,Quantitative Assays of Human Monocyte-Macrophage Function, J. Immun. Meth.8 213–222 (1975).
B.G. Holmes andR.A. Good,chronic Granulomatous Disease in Childhood, in:Immunbiology. Current Knowledge of Basic Concepts in Immunology and their Clinical Applications (Eds: R.A. Good and D.W. Fisher; Sinauer Associates, Inc. Publishers, Stamford, Conn., 1971).
H.U. Schorlemmer, J.H. Edwards, P. Davies andA.C. Allison,Macrophage Responses to Mouldy Hay Dust Micropolyspora Faeni and Zymosan, Activators of Complement by the Alternative Pathway, Clin. Exp. Immun.27, 198–207 (1977).
C. Bentley, D. Bitter-Suermann, U. Hadding andV. Brade,In Vitro Synthesis of Factor B of the Alternative Pathway of Complement Activation by Mouse Peritoneal Macrophages, Eur. J. Immun.6, 393–398 (1976)
R.L. Baehner andD.G. Nathan,Leukocyte Oxidase: Defective Activity in Chronic Granulomatous Disease, Science155, 835–836 (1967).
R. Kuhn andD. Jerchel,Über Invertseifen, VIII. Mitteil.: Reduktion von Tetrazoliumsalzen durch Bakterien, gärende Hefen und keimende Samen, Ber. dt. chem. Ges.74, 949–952 (1941).
B.M. Czarnetzki, D.H. Cowan andR.W. Belcher,The Effects of Polyanions on NBT Reduction Hexose Monophosphate Shunt Activity, and Ultrastructure of Polymorphonuclear Leucocytes, Am. J. clin. Path.64, 34–40 (1975).
B. Holmes, A.R. Page andR.A. Good,Studies of the Metabolic Activity of Leucocytes from Patients with a Genetic Abnormality of Phagocytic Function, J. clin. Invest.46, 1422–1432 (1967).
S.J. Klebanoff,Antimicrobial Mechanisms in Neutrophilic Polymorphonuclear Leucocytes, Seminars in Hematology XII, No. 2, 117–142 (1975).
M.L. Karnovsky,The Metabolism of Leucocytes, Seminars in Hematology V, No. 2, 156–165 (1968).
F.P. Altman,Quantitative Dehydrogenase Histochemistry with Special Reference to the Pentose Shunt Dehydrogenases, Prog. Histochem. Cytochem.4, No. 4, 225–273 (1972).
E. Ried,Formazane und Tetrazoliumsalze, ihre Synthesen und ihre Bedeutung als Reduktionsindikatoren und Vitalfarbstoffe, Angew. Chem.64, Nr. 14, 391–396 (1952).
A.W. Nineham,The Chemistry of Formazans and Tetrazoliumsalts, Chem. Rev.55, 355–483 (1955).
U. Pilgrim, W.H. Hitzig, J.J. Pl∭s andB. Ruckli,Nitrobluetetrazolium (NBT) Reduction in Leucocytes of Children with Acute Leukemia, Helv. paediat. Acta29, 315–323 (1974).
R.L. Baehner andD.G. Nathan,Quantitative Nitroblue Tetrazolium Test in Chronic Granulomatous Disease, New Engl. J. Med.278, 971–978 (1968).
T.P. Stossel,Evaluation of Opsonic and Leukocyte Function with a Spectrophotometric Test in Patients with Infection and with Phagocyte Disorders, Blood 42, 121–130 (1973).
F.P. Altman,Tetrazolium Salts and Formazans, Prog. Histochem. Cytochem.9, No. 3, 1–51 (1976).
L.W. Poulter andJ.L. Turk,Effect of Soluble Lymphocyte Products (Lymphokines) on Macrophage Physiology. I. Early Changes in Enzyme Activity and Permeability, Cellular Immun.20, 12–24 (1975).
K. Diem (Ed.),Documenta Geigy, Scientific Tables (J.R. Geigy S.A., Basel, 1962).
H. Beyer,Lehrbuch der organischen Chemie (S. Hirzel, Stuttgart, 1973).
E. Müller (Ed.),Methoden der organischen Chemie (Houben-Weyl), Bd. XI, 2: Stickstoffverbindungen I, Teil 2 (Thieme, Stuttgart, 1967), p. 371.
E. Müller (Ed.),Methoden der organischen Chemie (Houben-Weyl), Bd. VIII: Sauerstoffverbindungen III, (Thieme, Tuttgart, 1952), p. 68.
J. Müller,Die Stimulation des Hexosemonophosphat-Shunts des humanen polymorphkernigen Leukozyten durch künstliche Stimulanzien, durch Mediatoren des Komplementsystems und durch Lymphokine, Medical thesis, University of Mainz (in preparation).
M.N. Gleason, R.E. Gosselin andH.C. Hodge,Clinical Toxicology of Commercial Products (The Williams & Wilkins Co., Baltimore, 1963).
P. Herzer andE.-M. Lemmel,Inhibition of Granulocyte Function by; Prednisolone and Non-Steroid Anti-Inflammatory Drugs. Quantitative Evaluation with NBT Test and its Correlation with Phagocytosis, Immunobiol.157, 78–88 (1980).
P. Alfödy andE.-M. Lemmel,Reduction of Nitroblue Tetrazolium for Functional Evaluation of Activated Macrophages in the Cell-Mediated Immune Reaction, Clin. Immun. Immunopath.12, 263–270 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, J., Alföldy, P. & Lemmel, EM. Nitroblue-tetrazolium test for the functional evaluation of phagocytic cells: A critical analysis of the methodology. Agents and Actions 11, 384–390 (1981). https://doi.org/10.1007/BF01982475
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01982475